CABA-201 following preconditioning with fludarabine and cyclophosphamide
( DrugBank: Cyclophosphamide, Fludarabine / KEGG DRUG: Cyclophosphamide, Cyclophosphamide, Fludarabine phosphate, Fludarabine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 50 | Dermatomyositis | 1 |
50. Dermatomyositis
Clinical trials : 264 / Drugs : 298 - (DrugBank : 66) / Drug target genes : 71 - Drug target pathways : 173
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
